Previous close | 192.68 |
Open | 190.57 |
Bid | 169.10 |
Ask | 178.60 |
Strike | 280.00 |
Expiry date | 2025-01-17 |
Day's range | 190.57 - 192.68 |
Contract range | N/A |
Volume | |
Open interest | N/A |
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
Moderna stock is on the rise again as investors focus on the potential need for a bird flu vaccine. Is MRNA stock a buy right now?
Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.